Eleven Biotherapeutics Announces Corporate Name Change to Sesen Bio

Eleven Biotherapeutics Reports First Quarter Financial Results and Pipeline Updates

Celsius Therapeutics Launches with $65 Million in Series A Financing to Develop Precision Therapeutics For People with Autoimmune Diseases and Cancer

Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results

Kala Pharmaceuticals Reports First Quarter 2018 Financial Results